Chronic Kidney disease and stroke: A Bi-directional risk cascade and therapeutic update
Authors:
- Vishal ChavdaVCVishal Chavda
- Bipin ChaurasiaBCBipin Chaurasia
- Harsh DeoraHDHarsh Deora
- Giuseppe Emmanuele UmanaGUGiuseppe Emmanuele Umana
Open Access
- 1 September 2021
- journal article
- Published by Elsevier in Brain Disorders
- Vol. 3
Abstract
No abstract availableKeywords
This publication has 222 references indexed in Scilit:
- Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialAmerican Heart Journal, 2013
- Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney diseaseKidney International, 2013
- Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: Results of the Effect of Platelet Inhibition According to Clopidogrel Dose in Patients with Chronic Kidney Disease (PIANO-2 CKD) randomized studyAmerican Heart Journal, 2011
- Transient Focal Ischemia Induces Extensive Temporal Changes in Rat Cerebral MicroRNAomeJournal of Cerebral Blood Flow & Metabolism, 2009
- Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKDNephrology Dialysis Transplantation, 2008
- Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney diseaseKidney International, 2008
- Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ-diabetic rats by LR-9 and LR-74, novel AGE inhibitorsDiabetes/Metabolism Research and Reviews, 2005
- Neurological complications in renal failure: a reviewClinical Neurology and Neurosurgery, 2004
- Elevated risk of stroke among patients with end-stage renal diseaseKidney International, 2003
- The course of the remnant kidney model in miceKidney International, 1999